164 related articles for article (PubMed ID: 37547496)
1. Predicting Factors of Complete Pathological Response in Locally Advanced Rectal Cancer.
Latif A; Shirkhoda M; Rouhollahi MR; Nemati S; Yahyazadeh SH; Zendehdel K; Soroush AR; Yaghoobi Notash A
Middle East J Dig Dis; 2022 Oct; 14(4):443-451. PubMed ID: 37547496
[No Abstract] [Full Text] [Related]
2. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
3. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
4. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
6. Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer.
Restivo A; Zorcolo L; Cocco IM; Manunza R; Margiani C; Marongiu L; Casula G
Ann Surg Oncol; 2013 Mar; 20(3):864-71. PubMed ID: 23010737
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
8. Predicting rectal tumor response to neoadjuvant chemoradiotherapy using plasma levels of carcinoembryonic antigen (CEA): Results from a tertiary center in Iran.
Ahmadi Amoli H; Zarei R; Tayefeh Norooz M; Najjari K; Zabihi Mahmoudabadi H
J Taibah Univ Med Sci; 2022 Dec; 17(6):943-949. PubMed ID: 36212584
[TBL] [Abstract][Full Text] [Related]
9. Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer.
Yang J; Ling X; Tang W; Hu D; Zhou H; Yin G
J BUON; 2019; 24(1):77-83. PubMed ID: 30941954
[TBL] [Abstract][Full Text] [Related]
10. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy.
Sung S; Son SH; Kay CS; Lee YS
Medicine (Baltimore); 2016 Mar; 95(10):e2965. PubMed ID: 26962798
[TBL] [Abstract][Full Text] [Related]
11. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
[TBL] [Abstract][Full Text] [Related]
12. [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sun Y; Chi P; Xu B; Lin H; Lu X; Huang Y; Xu Z; Huang S; Jiang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):556-60. PubMed ID: 24953361
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Peng H; Wang C; Xiao W; Lin X; You K; Dong J; Wang Z; Yu X; Zeng Z; Zhou T; Gao Y; Wen B
J Cancer; 2018; 9(15):2687-2692. PubMed ID: 30087709
[TBL] [Abstract][Full Text] [Related]
14. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer.
Li A; He K; Guo D; Liu C; Wang D; Mu X; Yu J
Future Oncol; 2019 Oct; 15(28):3233-3242. PubMed ID: 31373223
[No Abstract] [Full Text] [Related]
16. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study.
Armstrong D; Raissouni S; Price Hiller J; Mercer J; Powell E; MacLean A; Jiang M; Doll C; Goodwin R; Batuyong E; Zhou K; Monzon JG; Tang PA; Heng DY; Cheung WY; Vickers MM
Clin Colorectal Cancer; 2015 Dec; 14(4):291-5. PubMed ID: 26433487
[TBL] [Abstract][Full Text] [Related]
18. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Zeng WG; Liang JW; Wang Z; Zhang XM; Hu JJ; Hou HR; Zhou HT; Zhou ZX
Chin J Cancer; 2015 Aug; 34(10):468-74. PubMed ID: 26268466
[TBL] [Abstract][Full Text] [Related]
19. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
Huang D; Lin Q; Song J; Xu B
Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
